€52.85
0.28% today
Borsa Italiana, Aug 28, 09:11 am CET
ISIN
IT0003828271
Symbol
REC

Recordati Stock price

€53.00
-0.65 1.21% 1M
-1.50 2.75% 6M
+2.40 4.74% YTD
+1.60 3.11% 1Y
+11.92 29.02% 3Y
+7.60 16.74% 5Y
+31.56 147.20% 10Y
+46.86 762.49% 20Y
Borsa Italiana, Closing price Wed, Aug 27 2025
+0.30 0.57%
ISIN
IT0003828271
Symbol
REC
Industry

Key metrics

Basic
Market capitalization
€11.1b
Enterprise Value
€13.2b
Net debt
€2.1b
Cash
€341.6m
Shares outstanding
205.6m
Valuation (TTM | estimate)
P/E
26.9 | 19.1
P/S
4.5 | 4.2
EV/Sales
5.3 | 5.0
EV/FCF
negative
P/B
5.9
Dividends
DPS
€1.27
Yield 1Y | 5Y
2.4% | 2.5%
Growth 1Y | 5Y
5.8% | 4.9%
Payout 1Y | 3Y
62.9% | 66.7%
Increased
12 Years
Financials (TTM | estimate)
Revenue
€2.5b | €2.7b
EBITDA
€851.7m | €995.3m
EBIT
€663.5m | €776.4m
Net Income
€407.3m | €571.4m
Free Cash Flow
€-298.9m
Growth (TTM | estimate)
Revenue
11.5% | 13.8%
EBITDA
13.4% | 20.2%
EBIT
11.3% | 17.4%
Net Income
5.2% | 37.2%
Free Cash Flow
-362.5%
Margin (TTM | estimate)
Gross
67.8%
EBITDA
34.4% | 37.4%
EBIT
26.8%
Net
16.4% | 21.5%
Free Cash Flow
-12.1%
Financial Health
Equity Ratio
36.6%
Return on Equity
22.2%
ROCE
16.2%
ROIC
11.8%
Debt/Equity
1.3
More
EPS
€2.0
FCF per Share
€-1.5
Short interest
-
Employees
5k
Rev per Employee
€520.0k
Show more

Is Recordati a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Recordati Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Recordati forecast:

7x Buy
47%
7x Hold
47%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Recordati forecast:

Buy
47%
Hold
47%
Sell
7%

Financial data from Recordati

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,480 2,480
12% 12%
100%
- Direct Costs 799 799
9% 9%
32%
1,681 1,681
13% 13%
68%
- Selling and Administrative Expenses 701 701
12% 12%
28%
- Research and Development Expense 314 314
14% 14%
13%
852 852
13% 13%
34%
- Depreciation and Amortization 188 188
21% 21%
8%
EBIT (Operating Income) EBIT 664 664
11% 11%
27%
Net Profit 407 407
5% 5%
16%

In millions EUR.

Don't miss a Thing! We will send you all news about Recordati directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Recordati SpA engages in the research, development, manufacturing, and marketing of pharmaceuticals. It operates through the following segments: Specialty & Primary Care and Rare Diseases Pharmaceuticals. The Specialty & Primary Care segment is related to pharmaceutical chemicals business. The Rare Diseases Pharmaceuticals segment, which relates to the Rare Diseases treatment. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Head office Italy
CEO Robert Koremans
Employees 4,539
Founded 1996
Website recordati.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today